VAERS reports by lot

Moderna COVID-19 lot 061B22A: VAERS reports

56 VAERS reports list lot 061B22A as a Moderna COVID-19 vaccine, received between 2022-08-02 and 2023-05-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
56
Reports
12%
Marked serious
1
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2322%
Cardiac / Cardiovascular1817%
Respiratory1413%
Injection-site / Local reaction1211%
Gastrointestinal1110%
Neurological77%
Dermatological (non-injection-site)66%
Allergic / Anaphylactic55%
Musculoskeletal44%
Thrombotic / Hematological33%
Psychiatric / Neuropsychiatric22%

Where reports came from

U.S. state of the reporter, where given (top 12).

Iowa9
Idaho7
Michigan6
Wisconsin5
Pennsylvania4
Georgia3
North Carolina2
Virginia2
South Carolina2
Ohio2
New York1
New Jersey1

Reports by month received

2022-0814
2022-0914
2022-105
2022-114
2022-127
2023-016
2023-024
2023-031
2023-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.